The Johns Hopkins University and the Institute of Organic Chemistry and Biochemistry Enter into Extended Drug Discovery Collaboration - 7/7/15

The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer, and gastrointestinal disorders.
Source: Johns Hopkins Medicine News - Category: Research Source Type: news